- Open Access
Detection of vitellogenin incorporation into zebrafish oocytes by FITC fluorescence
© Matsuda et al; licensee BioMed Central Ltd. 2011
- Received: 26 November 2010
- Accepted: 11 April 2011
- Published: 11 April 2011
Large volumes of lymph can be collected from the eye-sacs of bubble-eye goldfish. We attempted to induce vitellogenin (Vtg) in the eye-sac lymph of bubble-eye goldfish and develop a method for visualizing Vtg incorporation by zebrafish oocytes using FITC-labeling.
Estrogen efficiently induced Vtg in the eye-sac lymph of goldfish. After FITC-labeled Vtg was prepared, it was injected into mature female zebrafish.
Incorporation of FITC-labeled Vtg by zebrafish oocytes was detected in in vivo and in vitro experiments. The embryos obtained from zebrafish females injected with FITC-labeled Vtg emitted FITC fluorescence from the yolk sac and developed normally.
This method for achieving Vtg incorporation by zebrafish oocytes could be useful in experiments related to the development and endocrinology of zebrafish oocytes.
- Vitellogenic Oocyte
- Yolk Granule
- Follicular Stimulate Hormone
- FITC Fluorescence
- Fluorescence Stereomicroscope
Zebrafish (Danio rerio), a small teleost fish belonging to the family Cyprinidae, is widely used as a model organism in developmental biology and endocrinology. Most studies on oocyte development in zebrafish have focused on the elucidation of the molecular basis of vitellogenesis and oocyte maturation, with a particular emphasis on the molecular aspects of maternal mRNA accumulation associated with axial formation during early embryogenesis [1, 2]. Vitellogenin (Vtg) is a female-specific phospholipoglycoprotein that is secreted by the liver and taken up by growing/vitellogenic oocytes where it is processed and stored as yolk proteins in the ooplasm [1, 2]. The development of systems for both visualizing the incorporation of Vtg into oocytes and for allowing Vtg incorporation in vitro would be particularly useful in the fields of endocrinology and embryology. The in vitro oocyte culture systems that have been developed in the rainbow trout and eel to date both use Vtg prepared from the plasma of these species [3, 4]. However, since obtaining sufficiently large volumes of zebrafish plasma for Vtg preparation is complicated by their small body size, developing an alternate source of Vtg for incorporation into the cytoplasm of zebrafish oocytes would be beneficial.
A system for synthesizing and incorporating Vtg into the oocytes of teleosts such as zebrafish has recently been reviewed [1, 5]. Briefly, follicular stimulating hormone (FSH) from the pituitary stimulates the follicular cells surrounding the oocytes to produce estrogen (E2), which then stimulates Vtg synthesis in the liver. Once secreted into the plasma by the liver, the Vtg is quickly incorporated into the yolk granules of the oocytes by a plasma membrane Vtg-receptor (VtgR) system. The incorporation of Vtg into oocytes has been reported to be stimulated by FSH in rainbow trout (Salmo gairdneri) . At this vitellogenic stage, the oocytes increase rapidly in size and accumulate fat-soluble vitamin A metabolites, such as retinal, which are essential for embryogenesis [7, 8]. At the same time, maternal mRNAs related to germline specification and axial formation in embryos are transcribed and accumulate in the oocytes during vitellogenesis [2, 9–11]. The Vtg that is stored in the yolk functions as a source of amino acids, lipids, and sugars during embryogenesis [1, 2]. Interestingly, the administration of exogenous E2 has been experimentally shown to induce Vtg synthesis in the livers of both male and female rainbow trout .
Experiment 1: E2-induced Vtg accumulation in eye-sac lymph of bubble-eye goldfish
Bubble-eye goldfish and zebrafish were purchased from a local pet shop in Sendai, Japan. All of the fish were maintained at 28°C under photoperiod conditions of 14 h light and 10 h dark. Fish were anesthetized with MS-222 (Wako Pure Chemical Industries, Osaka, Japan) before E2 (Wako) injection and lymph collection. Fifty μl of dimethyl sulfoxide (Wako) containing E2 at 0.12 ng/μl was injected into the abdominal cavities of male and female bubble-eye goldfish weighing approximately 20 g. Lymph was collected from the eye-sac using a plastic syringe immediately before the injection of E2 and then 7 days thereafter. Collected lymph was boiled for 5 min with sodium dodecyl sulfate (SDS) and 2-mercaptoethanol (Wako), and then subjected to SDS-polyacrylamide gel electrophoresis (PAGE) . The protein bands were stained with Coomassie Brilliant Blue R-250.
Experiment 2: Preparation of FITC-labeled Vtg
For the preparation of FITC-labeled Vtg, E2 was injected into the abdominal cavity three times over a seven-day period to induce high concentrations of Vtg in eye-sac lymph. Lymph was then collected from the eye sac four days after the final E2 injection. A total of approximately 2 ml of lymph was obtained from both eye sacs of one fish. Obtained lymph was dialyzed against 0.05 M Na2CO3/NaHCO3 (sodium carbonate) buffer (pH9.5) overnight at 4°C. Fluorescein 5(6)-isothiocyanate (FITC; Wako) was dissolved in sodium carbonate buffer to a concentration of 10% and added to the dialyzed lymph at a ratio of 1:100, before being incubated at 4°C in the dark for 6 h to facilitate FITC conjugation. The lymph was then dialyzed twice against phosphate buffered saline (PBS) for 12 h at 4°C to remove unconjugated FITC; this solution is referred to as FITC-labeled Vtg solution hereafter. To confirm that FITC had covalently bonded to the Vtg, the sample was subjected to SDS-PAGE and irradiated with UV light to detect FITC-labeled proteins. As controls, we prepared FITC-labeled lymph proteins from male goldfish without E2 treatment and FITC-labeled bovine serum albumin (BSA; Rockland, Philadelphia, USA).
To separate the FITC-labeled Vtg from low molecular weight lymph proteins, 200 μl of FITC-labeled Vtg solution was eluted through a Sephacryl S-200 HR (GE Healthcare, Little Charfont, England) column (1 cm × 30 cm). Protein elution was monitored by FITC-fluorescence and the first peak was identified as the FITC-labeled, purified Vtg.
Experiment 3: Monitoring incorporation of fluorescent Vtg in vivo
One hundred μl of FITC-labeled Vtg solution prepared as described above was injected into the abdominal cavities of zebrafish (n = 10) that had started spawning. Observations in zebrafish were performed after anesthetization with MS-222 and dissection of the left side of the abdomen. Incorporation of FITC-labeled Vtg into oocytes was examined using a Leica MZ15F fluorescence stereomicroscope (Wetzlar, Germany). Photographs were taken using a Leica DFC500 digital CCD camera (Wetzlar, Germany) and processed using Adobe Photoshop (version 7, Adobe Inc., San Jose, CA). To observe the intracellular localization of FITC-labeled Vtg, some of experimental fish were fixed in 4% paraformaldehyde in PBS, embedded in paraffin, and cut into 8 μm sections for observation under the fluorescence stereomicroscope after paraffin removal.
Experiment 4: Assessing viability of zebrafish oocytes after incorporation of goldfish Vtg
Zebrafish females injected with FITC-labeled Vtg were maintained in a tank and mated with males. Fertilized eggs exhibiting FITC fluorescence were collected and reared.
Experiment 5: Monitoring incorporation of fluorescent Vtg in vitro
The ovaries of a mature female zebrafish that had been anesthetized and sterilized in 0.2% sodium hypochlorite solution for 5 min were removed and washed three times in L15 medium. The ovaries were then separated into tissue explants containing 20-40 oocytes using forceps. Explants were then cultured at 28°C in the L15 medium as described by Sawatari et al. , except that 2% FITC labeled-Vtg solution, 5% fetal bovine serum (Sigma, St. Louis, MO), 200 ng/ml of carp pituitary acetone power (Sigma), and 5 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; Wako) (pH7.2) were added to the medium.
To examine whether heterogeneous Vtg prepared from goldfish could be incorporated by zebrafish oocytes, FITC-labeled Vtg solution prepared as described above was injected into the abdominal cavities of females and FITC fluorescence was then traced in the specimen under a fluorescent microscope. Although FITC fluorescence was detected in the ovary at 24 h after injection, incorporation into oocytes was not yet apparent (Figure 3B). However, at 48 and 72 h after injection, strong FITC fluorescence was detected in vitellogenic oocytes (Figure 3C,D), with sectioning of the ovaries revealing that yolk granules emitted FITC fluorescence (Figure 3E). When purified FITC-labeled Vtg was injected into females, zebrafish oocytes also started emitting FITC fluorescence (Figure 3F).
To examine the stability of goldfish Vtg in zebrafish, body fluid (approximately 1 μl) emitting FITC fluorescence was collected from the abdominal cavity of zebrafish under a fluorescence stereomicroscope at 24 h after injection, and subjected to SDS-PAGE analysis. A FITC-positive band was detected at the position of the original Vtg molecular weight, indicating that goldfish Vtg remained relatively stable in the zebrafish body fluid and did not degrade rapidly (Figure 3A).
As controls for determining whether zebrafish oocytes specifically incorporate goldfish Vtg as a yolk protein precursor, we prepared FITC-labeled, male lymph proteins from gold fish and FITC-labeled BSA (Figure 3G,H), and injected these into female zebrafish; neither of these control preparations was incorporated into in the oocytes (Figure 3G,H). Taken together, these findings indicated that the zebrafish oocytes incorporated the FITC-labeled goldfish Vtg into the yolk granules.
We demonstrated that Vtg can be induced by E2 injection in the eye-sac lymph of bubble-eye goldfish, and that the induced Vtg can be conjugated with FITC using a standard technique. Both female and male goldfish can be used for Vtg preparation, with three injections of E2 administered over a seven-day period being sufficient for obtaining enough Vtg for FITC-labeling. We also demonstrated that it was possible to monitor Vtg incorporation into zebrafish oocytes by FITC fluorescence, both in vivo and in vitro. By using a recently developed transparent zebrafish line , it would be possible to monitor the incorporation of FITC-labeled Vtg in a living specimen.
In addition, when accumulated in yolk, goldfish Vtg did not affect zebrafish oocyte development and subsequent embryogenesis, even though the Vtg was heterogeneous in origin. Approximately 2 ml of lymph can be harvested from the eye-sacs of bubble-eye goldfish weighing 20 g, which is sufficient for performing the Vtg incorporation experiment in 20 zebrafish and for preparing 60 ml of culture medium for examining Vtg incorporation into oocytes. The eye-sac lymph of bubble-eye goldfish is thus considered to be a superior source of Vtg for developmental and endocrine experiments using zebrafish oocytes.
This method is important because there are two possible supplemental sources of exogenous Vtg for oocyte development, recombinant Vtg and plasma- or lymph-derived Vtg. Since preparing a structurally complicated phospholipoglycoprotein, like Vtg, using recombinant protein methods is difficult, the application of plasma- or lymph-derived Vtg is considered to be preferable. We propose that Vtg induced in the eye-sac lymph is well suited for use as a source of Vtg for studies on zebrafish oocyte development. In addition, several possible applications of FITC-labeled Vtg prepared from goldfish exist. First, the effects of hormones on Vtg incorporation into zebrafish oocytes could be quantified by determining the FITC content of oocytes after hormonal treatment. Second, further development of a culture system using FITC-labeled Vtg may facilitate the culture of zebrafish oocytes in vitro. Third, goldfish Vtg may function as a carrier for introducing external proteins, such as antibodies, into zebrafish oocytes by conjugation with Vtg.
We developed methods for preparing FITC-labeled Vtg from the eye-sac lymph of bubble-eye goldfish and for visualizing Vtg incorporation by zebrafish oocytes in in vitro and in vivo systems using FITC-labeled goldfish Vtg.
We thank Dr Akihiko Hara of Hokkaido University for advice on Vtg induction. This research was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan to TS (22380104, 22658063).
- Clelland E, Peng C: Endocrine/paracrine control of zebrafish ovarian development. Mol Cell Endocrinol. 2009, 312: 42-52. 10.1016/j.mce.2009.04.009.View ArticlePubMedGoogle Scholar
- Abrams EW, Mullins MC: Early zebrafish development: it's in the maternal genes. Curr Opin Genet Dev. 2009, 19: 396-403. 10.1016/j.gde.2009.06.002.PubMed CentralView ArticlePubMedGoogle Scholar
- Kayaba T, Sasaki N, Adachi S, Yamauchi K: Effects of pituitary glycoprotein hormones and thyroid hormones on in-vitro vitellogenin incorporation into organ-cultured oocytes in the Japanese eel, Anguilla japonica. Zool Sci. 2008, 25: 334-343. 10.2108/zsj.25.334.View ArticlePubMedGoogle Scholar
- Tyler CR, Sumpter JP, Bromage NR: An in vitro culture system for studying vitellogenin uptake into ovarian follicles of the rainbow trout, Salmo gairdneri. J Exp Zool. 1990, 255: 216-231. 10.1002/jez.1402550210.View ArticleGoogle Scholar
- Lubzens E, Young G, Bobe J, Cerda J: Oogenesis in teleosts: how eggs are formed. Gen Comp Endocrinol. 2010, 165: 367-389. 10.1016/j.ygcen.2009.05.022.View ArticlePubMedGoogle Scholar
- Tyler CR, Sumpter JP, Kawauchi H, Swanson P: Involvement of gonadotropin in the uptake of vitellogenin into vitellogenic oocytes of the rainbow trout, Oncorhynchus mykiss. Gen Comp Endocrinol. 1991, 84: 291-299. 10.1016/0016-6480(91)90052-8.View ArticlePubMedGoogle Scholar
- Costaridis P, Horton C, Zeitlinger J, Holder N, Maden M: Endogenous retinoids in the zebrafish embryo and adult. Dev Dyn. 1996, 205: 41-51. 10.1002/(SICI)1097-0177(199601)205:1<41::AID-AJA4>3.0.CO;2-5.View ArticlePubMedGoogle Scholar
- Lubzens E, Lissauer L, Levavi-Sivan B, Avarre JC, Sammar M: Carotenoid and retinoid transport to fish oocytes and eggs: what is the role of retinol binding protein?. Mol Aspects Med. 2003, 24: 441-457. 10.1016/S0098-2997(03)00040-2.View ArticlePubMedGoogle Scholar
- Knaut H, Pelegri F, Bohmann K, Schwarz H, Nusslein-Volhard C: Zebrafish vasa RNA but not its protein is a component of the germ plasm and segregates asymmetrically before germline specification. J Cell Biol. 2000, 149: 875-888. 10.1083/jcb.149.4.875.PubMed CentralView ArticlePubMedGoogle Scholar
- Pelegri F: Maternal factors in zebrafish development. Dev Dyn. 2003, 228: 535-554. 10.1002/dvdy.10390.View ArticlePubMedGoogle Scholar
- Reim G, Brand M: Maternal control of vertebrate dorsoventral axis formation and epiboly by the POU domain protein Spg/Pou2/Oct4. Development. 2006, 133: 2757-2770. 10.1242/dev.02391.View ArticlePubMedGoogle Scholar
- Le Guellec K, Lawless K, Valotaire Y, Kress M, Tenniswood M: Vitellogenin gene expression in male rainbow trout (Salmo gairdneri). Gen Comp Endocrinol. 1988, 71: 359-371. 10.1016/0016-6480(88)90264-X.View ArticlePubMedGoogle Scholar
- Sawatari E, Hashimoto H, Matsumura T, Iwata Y, Yamamoto N, Yokoyama Y, Wakamatsu Y: Cell growth-promoting activity of fluid from eye sacs of the bubble-eye goldfish (Carassius auratus). Zool Sci. 2009, 26: 254-258. 10.2108/zsj.26.254.View ArticlePubMedGoogle Scholar
- Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-685. 10.1038/227680a0.View ArticlePubMedGoogle Scholar
- Fukada H, Fujiwara Y, Takahashi T, Hiramatsu N, Sullivan CV, Hara A: Carp (Cyprinus carpio) vitellogenin: purification and development of a simultaneous chemiluminescent immunoassay. Comp Biochem Physiol A Mol Integr Physiol. 2003, 134: 615-623. 10.1016/S1095-6433(02)00348-3.View ArticlePubMedGoogle Scholar
- White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, Bourque C, Dovey M, Goessling W, Burns CE, Zon LI: Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell. 2008, 2: 183-189. 10.1016/j.stem.2007.11.002.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.